Infection and graft versus host disease are still the two major causes of morbidity and mortality during bone marrow transplantation, and they represent the most important barriers to immediate and long term survival. ' 2 Acute graft versus host disease may be initiated or exacerbated by infection,3 and studies in animals4 and man56 have shown that the recipient' s microbial environment may significantly modify the incidence and course of the disease. Acute graft versus host disease and its treatment with immunosuppressive drugs increases the incidence of infection,7 while the empirical use of broad spectrum antibiotics may increase the risk from invasive fungal infections.8 There would therefore be obvious value for any laboratory investigation that could be used in the differential diagnosis and monitoring of these complications, which are often difficult to distinguish clinically and may occur simultaneously.
Infections, particularly bacterial, are associated with an acute phase response, during which the concentrations of many serum proteins are altered.9 The nature of the acute phase response in acute graft versus host disease has not been fully investigated. charge (up to 3 months after transplant) or death had a total of 116 clearly documented episodes of infection or acute graft versus host disease or both. They had been transplanted for acute leukaemia (34), chronic granulocytic leukaemia (2), severe aplastic anaemia (6) , and various inborn errors of metabolism (26) . Serum CRP concentrations were measured by rate nephelometry on a Beckman ICS analyser using Beckman reagent kits (Beckman Instruments Inc, Fullerton California 92634, USA) on samples taken regularly from inpatients. The limit of sensitivity was 6 mg/l, and 10 mg/l was taken as the upper limit of normal. 23 The coefficient of variation in replicate assays was 6%.
The diagnosis of most bacterial and fungal infections was confirmed by positive culture and supported by a response to appropriate treatment. The diagnosis of viral infections was by electron microscopy, virus isolation, or significantly rising viral antibody titres. In the few patients in whom a causative agent was not identified there was strong clinical evidence of infection or response to treatment or both.
The diagnosis of acute graft versus host disease was usually confirmed by positive biopsy findings in patients developing typical clinical manifestations. 24 Infection prophylaxis included intestinal decon- 
